🇺🇸 FDA
Patent

US 9539341

Methods and compositions for targeting adipose cells in mammals

granted A61KA61K38/00A61K38/10

Quick answer

US patent 9539341 (Methods and compositions for targeting adipose cells in mammals) held by The Board of Regents of the University of Texas System expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/00, A61K38/10, A61K47/64, A61P